These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11198135)
1. Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Nathan PJ; Sitaram G; Stough C; Silberstein RB; Sali A Behav Pharmacol; 2000 Nov; 11(7-8):639-42. PubMed ID: 11198135 [TBL] [Abstract][Full Text] [Related]
2. The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers. Siepmann T; Mueck-Weymann M; Oertel R; Kirch W; Pittrow D; Siepmann M Pharmacopsychiatry; 2008 Jul; 41(4):146-50. PubMed ID: 18651343 [TBL] [Abstract][Full Text] [Related]
3. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors. Weikop P; Kehr J; Scheel-Krüger J J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160 [TBL] [Abstract][Full Text] [Related]
4. Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. O'Hanlon JF; Robbe HW; Vermeeren A; van Leeuwen C; Danjou PE J Clin Psychopharmacol; 1998 Jun; 18(3):212-21. PubMed ID: 9617980 [TBL] [Abstract][Full Text] [Related]
5. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. David DJ; Bourin M; Jego G; Przybylski C; Jolliet P; Gardier AM Br J Pharmacol; 2003 Nov; 140(6):1128-36. PubMed ID: 14530210 [TBL] [Abstract][Full Text] [Related]
6. In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation. Hallbäck I; Hägg S; Eriksson AC; Whiss PA Pharmacol Rep; 2012; 64(4):979-83. PubMed ID: 23087151 [TBL] [Abstract][Full Text] [Related]
7. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919 [TBL] [Abstract][Full Text] [Related]
8. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476 [TBL] [Abstract][Full Text] [Related]
9. Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus. Cooke JD; Cavender HM; Lima HK; Grover LM Psychopharmacology (Berl); 2014 Dec; 231(23):4429-41. PubMed ID: 24781518 [TBL] [Abstract][Full Text] [Related]
10. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Dawson LA; Nguyen HQ; Geiger A Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein. Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM Br J Clin Pharmacol; 1999 Sep; 48(3):345-54. PubMed ID: 10510145 [TBL] [Abstract][Full Text] [Related]
12. Neurochemical modulation of response inhibition and probabilistic learning in humans. Chamberlain SR; Müller U; Blackwell AD; Clark L; Robbins TW; Sahakian BJ Science; 2006 Feb; 311(5762):861-3. PubMed ID: 16469930 [TBL] [Abstract][Full Text] [Related]
13. Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges. Apelqvist G; Wikell C; Hindfelt B; Bergqvist PB; Andersson G; Bengtsson F Psychopharmacology (Berl); 1999 Apr; 143(4):408-16. PubMed ID: 10367559 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man. Bitsios P; Szabadi E; Bradshaw CM Psychopharmacology (Berl); 1999 Apr; 143(3):286-92. PubMed ID: 10353432 [TBL] [Abstract][Full Text] [Related]
15. SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects. Paul MA; Gray GW; Love RJ; Lange M Aviat Space Environ Med; 2007 Jul; 78(7):693-7. PubMed ID: 17679567 [TBL] [Abstract][Full Text] [Related]
16. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat. Béïque J; de Montigny C; Blier P; Debonnel G Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561 [TBL] [Abstract][Full Text] [Related]
17. Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex. Hatanaka K; Yatsugi S; Yamaguchi T Eur J Pharmacol; 2000 Apr; 395(1):31-6. PubMed ID: 10781670 [TBL] [Abstract][Full Text] [Related]
18. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder. Foster RH; Goa KL CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224 [TBL] [Abstract][Full Text] [Related]
19. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Harmer CJ; Shelley NC; Cowen PJ; Goodwin GM Am J Psychiatry; 2004 Jul; 161(7):1256-63. PubMed ID: 15229059 [TBL] [Abstract][Full Text] [Related]
20. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]